• QXO, Inc. is preparing to report June 2026 quarterly results that analysts expect will show an earnings decline even as revenues increase year over year.
• An unusual tension has emerged between a sharply revised-up consensus earnings estimate and a lower “Most Accurate Estimate,” producing a negative Earnings ESP and tempering optimism about an earnings beat.
• With QXO’s recent performance set against mixed earnings expectations and a negative Earnings ESP, we’ll examine how this shapes its investment narrative.

Find 51 companies with promising cash flow potential yet trading below their fair value.

What Is QXO's Investment Narrative?

To own QXO here, you really have to believe in the bigger build‑out story: Brad Jacobs assembling a scaled building‑products distributor through large acquisitions like TopBuild, funded by significant new debt and equity. The latest earnings setup, with analysts expecting higher revenue but weaker earnings and a negative Earnings ESP, mostly reinforces what the stock already trades on in the short term: execution on integration, balance‑sheet risk and the timing of any path toward profitability. The news may dampen hopes for a clean earnings surprise, but it does not fundamentally change the near‑term catalysts, which still center on how efficiently QXO absorbs TopBuild, manages interest costs on its new US$3.00 billion of notes, and handles continued shareholder dilution. If margins disappoint again, though, that balance‑sheet and dilution risk will matter more quickly than bulls might like.

However, investors should be aware of how quickly leverage and dilution could pressure the equity story. QXO's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.

Exploring Other Perspectives

Nine fair value estimates from the Simply Wall St Community span roughly US$5 to just under US$53 per share, underscoring how differently people see QXO’s potential. Set against an earnings outlook that still points to losses and higher financing obligations, this dispersion challenges you to weigh balance‑sheet and integration risks carefully while exploring several contrasting viewpoints on where the business might ultimately settle.

Explore 9 other fair value estimates on QXO - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your QXO research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free QXO research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate QXO's overall financial health at a glance.

Ready For A Different Approach?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• The future of work is here. Discover the 36 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.